The efficacy of TKI maintenance therapy after allo-HSCT in patients with high-risk Ph+ ALL

Keiko Fukunaga

Presentation information

Oral Session

Oral Session 2-12D Ph+ALL

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.12 (Tokyo International Forum, 5F G510)

Chair: Nobuaki Dobashi (Division of Clinical Oncology and Hematology, The Jikei University Daisan Hospital)

[OS2-12D-2] The efficacy of TKI maintenance therapy after allo-HSCT in patients with high-risk Ph+ ALL

Keiko Fukunaga, Kazuhiro Ikegame, Katsuji Kaida, Takayuki Inoue, Satoshi Yoshihara, Kyoko Yoshihara, Yuko Osugi, Hiroya Tamaki, Masaya Okada, Hiroyasu Ogawa, Yoshihiro Fujimori (Division of Hematology, Hyogo College of Medicine)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.